Stifel analyst Justin Keywood maintained his “Buy” rating and $9.00 target price on WELL Health Technologies (WELL Health Technologies Stock Quote, Chart, News, Analysts, Financials TSX:WELL) in an Aug. 21 report, pointing to catalysts from divestitures, M&A, and the company’s fast-growing software platform. “WELL has an ecosystem of over 80 healthcare assets, where there exists substantial value to […]
Paradigm Capital analyst Daniel Rosenberg maintained his “Buy” rating and raised his 12-month target to $8.00 from $7.75 for WELL Health Technologies (WELL Health Technologies Stock Quote, Chart, News, Analysts, Financials TSXV:WELL). He said in an August 14 research note that the company reported Q2 results ahead of expectations, supported by both organic growth and […]
Share
Tweet
Share
